Puma Biotechnology Valuation
| PBYI Stock | USD 3.39 0.16 4.95% |
At this time, the company appears to be undervalued. Puma Biotechnology holds a recent Real Value of $3.76 per share. The prevailing price of the company is $3.39. Our model determines the value of Puma Biotechnology from analyzing the company fundamentals such as Return On Equity of 0.42, shares outstanding of 49.09 M, and Operating Margin of 0.27 % as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Puma Biotechnology's valuation include:
Price Book 2.2304 | Enterprise Value 148.2 M | Enterprise Value Ebitda 2.9986 | Price Sales 0.6832 | Forward PE 4.3649 |
Undervalued
Today
Please note that Puma Biotechnology's price fluctuation is unstable at this time. Calculation of the real value of Puma Biotechnology is based on 3 months time horizon. Increasing Puma Biotechnology's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Puma Biotechnology is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Puma Stock. However, Puma Biotechnology's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3.39 | Real 3.76 | Target 5.0 | Hype 3.21 | Naive 3.39 |
The intrinsic value of Puma Biotechnology's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Puma Biotechnology's stock price.
Estimating the potential upside or downside of Puma Biotechnology helps investors to forecast how Puma stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Puma Biotechnology more accurately as focusing exclusively on Puma Biotechnology's fundamentals will not take into account other important factors: When choosing an evaluation method for Puma Biotechnology, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using all methods to arrive at a better estimate.
Puma Biotechnology Cash |
|
Puma Valuation Trend
Puma Biotechnology's real value analysis enables investors to forecast the earnings more efficiently. Using both Puma Biotechnology's enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing decisions.
Puma Revenue by Product
Puma Biotechnology Total Value Analysis
Puma Biotechnology is at this time anticipated to have valuation of 148.2 M with market capitalization of 166.41 M, debt of 111.49 M, and cash on hands of 77.96 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Puma Biotechnology fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
148.2 M | 166.41 M | 111.49 M | 77.96 M |
Puma Biotechnology Investor Information
About 15.0% of the company outstanding shares are owned by corporate insiders. The book value of Puma Biotechnology was at this time reported as 1.45. The company has Price/Earnings To Growth (PEG) ratio of 0.03. Puma Biotechnology had not issued any dividends in recent years. Based on the key measurements obtained from Puma Biotechnology's financial statements, Puma Biotechnology may be sliding down financialy. It has an above-average odds of going through some form of financial crisis next quarter.Puma Biotechnology Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Puma Biotechnology has an asset utilization ratio of 102.22 percent. This signifies that the Company is making $1.02 for each dollar of assets. An increasing asset utilization means that Puma Biotechnology is more efficient with each dollar of assets it utilizes for everyday operations.Puma Biotechnology Ownership Allocation
Puma Biotechnology owns a total of 49.09 Million outstanding shares. Over half of Puma Biotechnology's outstanding shares are owned by third-party entities. These third-party entities are typically referred to as corporate investors that secure positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.Puma Biotechnology Profitability Analysis
The company reported the previous year's revenue of 235.64 M. Net Income was 21.59 M with profit before overhead, payroll, taxes, and interest of 172.94 M.About Puma Biotechnology Valuation
An absolute valuation paradigm, as applied to Puma Stock, attempts to find the value of Puma Biotechnology based on its fundamental and basic technical indicators. By analyzing Puma Biotechnology's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Puma Biotechnology's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Puma Biotechnology. We calculate exposure to Puma Biotechnology's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Puma Biotechnology's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 173 M | 101.1 M | |
| Pretax Profit Margin | 0.10 | 0.09 | |
| Operating Profit Margin | 0.14 | 0.13 | |
| Net Profit Margin | 0.09 | 0.09 | |
| Gross Profit Margin | 0.73 | 0.88 |
Puma Biotechnology Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 47.6 M | |
| Quarterly Earnings Growth Y O Y | 2.417 | |
| Forward Price Earnings | 4.3649 |
Puma Biotechnology Current Valuation Indicators
Valuation refers to the process of determining the present value of Puma Biotechnology and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Puma we look at many different elements of the entity such as Puma's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Puma Biotechnology, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Puma Biotechnology's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Puma Biotechnology's worth.Complementary Tools for Puma Stock analysis
When running Puma Biotechnology's price analysis, check to measure Puma Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Puma Biotechnology is operating at the current time. Most of Puma Biotechnology's value examination focuses on studying past and present price action to predict the probability of Puma Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Puma Biotechnology's price. Additionally, you may evaluate how the addition of Puma Biotechnology to your portfolios can decrease your overall portfolio volatility.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |